World's First Recombinant Botulinum Toxin Type A New Drug Received Marketing Approval in China: a Technological Revolution pioneered by Claruvis Pharmaceutical
CHONGQING, China, April 28, 2026 /PRNewswire/ -- Chongqing Claruvis Pharmaceutical Co., Ltd. recently announced that the China's National Medical Products Administration (NMPA) has approved its Retoxin® (recombinant botulinum toxin type A, project...
Getinge Interim Report January-March 2026: Organic growth, strong cash flow and regulatory milestone
GOTHENBURG, Sweden, April 21, 2026 /PRNewswire/ -- "We succeeded in surpassing last year's record-breaking first quarter with organic growth in both net sales and order intake," says Mattias Perjos, President & CEO at Getinge. The medtech...
Innovations Centered on 'A Better Life for Customers' Win at LG Awards
SEOUL, South Korea, April 20, 2026 /PRNewswire/ -- Innovations focused on a better life for customers were recognized for their outstanding impact at the LG Awards. Four projects that generated tangible results, such as increased sales and orders,...
SST001, an α-syn PET tracer from Mabwell's incubated company SynuSight Biotech, received NMPA approval to initiate a clinical trial
SHANGHAI, April 15, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that 18F-FD4 (R&D code: SST001), an α-synuclein (α-syn) targeted PET tracer...
HiTHIUM's kAh-Level 6.25MWh BESS Receives International Certification Following Large-Scale Fire Test
BEIJING, April 3, 2026 /PRNewswire/ -- HiTHIUM showcased its full-scenario energy storage solutions at ESIE 2026, held in Beijing from April 1-3. The company highlighted its ∞Cell 1175Ah long-duration energy storage (LDES) battery and BESS, along...
Cyble Secures Dual Industry Honors with Major Wins at Global InfoSec Awards 2026 and Cybersecurity Excellence Awards
CUPERTINO, Calif., March 26, 2026 /PRNewswire/ -- Cyble, a global leader in AI-powered cybersecurity solutions, announced major recognition across two of the industry's most prestigious award programs. The company received the Gold Award for Threat...
Seveno Capital Invests in PointFit as Next-Generation Wearable Patch Signals a Break from Traditional Wearable Devices
Investment in PointFit anchors Seveno's Hong Kong expansion and marks first deal led by new Partner Jean-Baptiste Roy HONG KONG, March 9, 2026 /PRNewswire/ -- Seveno Capital has announced a strategic investment in PointFit, a company developing a...
Delonix Bioworks Announces IND Clearance for DX-104, a Novel Engineered MenB OMV Vaccine Candidate, in China and Australia
SHANGHAI, Feb. 6, 2026 /PRNewswire/ -- Delonix Bioworks, a clinical-stage biotechnology company developing next-generation bacterial vaccines, recently announced that its Group B meningococcal (MenB) vaccine candidate, DX-104, has received...
Getinge Q4 and Full-Year Report 2025: Organic growth and solid cash flow to end the year
GOTHENBURG, Sweden, Jan. 27, 2026 /PRNewswire/ -- "We succeeded in growing organically, delivering a record-breaking fourth quarter and organic growth at the upper end of our forecast, 4.9% for the full year," says Mattias Perjos, President &...
TIAN RUIXIANG Holdings Ltd. Announces Receipt of Nasdaq Delisting Notification Regarding Minimum Bid Price Deficiency
BEIJING, Jan. 27, 2026 /PRNewswire/ -- TIAN RUIXIANG Holdings Ltd. (Nasdaq: TIRX) (the "Company" or "TRX") today announced that it had received a written notification (the "Notice") from the Listing Qualifications (the "Staff") of The Nasdaq Stock...